XARELTO® is approved by the FDA to help reduce the risk of blood clots in common conditions like atrial fibrillation (AFib), deep vein thrombosis (DVT), and pulmonary embolism (PE). It is also approved for conditions for which no other anticoagulant has been approved before, such as coronary artery disease (CAD) and peripheral artery disease (PAD). More than 40 million people worldwide have been prescribed XARELTO®.
Get Started by Choosing Your Condition Below:
Heart-related
For a customized experience, choose the option below that best applies to you:
For a customized experience, choose the option below that best applies to you:
Surgery
For a customized experience, choose the option below that best applies to you: